Release Date: 11/08/20 09:37 Summary: Appendix 4G and Corporate Governance Statement Price Sensitive: No Download Document 1.12MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%